Document ID: SEC-2021-1140-0001
Agency: sec
Document Type: Notice
Title: Self-Regulatory Organizations; Proposed Rule Changes: New York Stock Exchange, LLC
Posted Date: 2021-08-24T04:00Z

[Federal Register Volume 86, Number 161 (Tuesday, August 24, 2021)]
[Notices]
[Pages 47351-47355]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18119]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-92700; File No. SR-NYSE-2020-96]

Self-Regulatory Organizations; New York Stock Exchange LLC; Order 
Disapproving a Proposed Rule Change To Amend Its Rules Establishing 
Maximum Fee Rates To Be Charged by Member Organizations for Forwarding 
Proxy and Other Materials to Beneficial Owners

August 18, 2021.

I. Introduction

    On December 2, 2020, New York Stock Exchange LLC (``NYSE'' or 
``Exchange'') filed with the Securities and Exchange Commission 
(``SEC'' or ``Commission''), pursuant to Section 19(b)(1) of the 
Securities Exchange Act of 1934 (``Act'') \1\ and Rule 19b-4 
thereunder,\2\ a proposed rule change to delete the maximum fee rates 
for forwarding proxy and other materials to beneficial owners set forth 
in NYSE Rules 451 and 465 and Section 402.10 of the NYSE Listed Company 
Manual (``Manual''), and establish in their place a requirement for 
member organizations to comply with any schedule of approved charges 
set forth in the rules of any other national securities exchange or 
association of which such member organization is a member. The proposed 
rule change was published for comment in the Federal Register on 
December 21, 2020.\3\
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ See Securities Exchange Act Release No. 90677 (December 15, 
2020), 85 FR 83119 (December 21, 2020) (``Notice''). Comments 
received on the proposal are available on the Commission's website 
at: https://www.sec.gov/comments/sr-nyse-2020-96/srnyse202096.htm.
---------------------------------------------------------------------------

    On February 1, 2021, pursuant to Section 19(b)(2) of the Act,\4\ 
the Commission designated a longer period within which to approve the 
proposed rule change, disapprove the proposed rule change, or institute 
proceedings to determine whether to approve or

[[Page 47352]]

disapprove the proposed rule change.\5\ On March 18, 2021, the 
Commission instituted proceedings under Section 19(b)(2)(B) of the Act 
\6\ to determine whether to approve or disapprove the proposed rule 
change.\7\ On June 11, 2021, the Commission designated a longer period 
for Commission action on the proposed rule change.\8\
---------------------------------------------------------------------------

    \4\ 15 U.S.C. 78s(b)(2).
    \5\ See Securities Exchange Act Release No. 91025 (February 1, 
2021), 86 FR 8420 (February 5, 2021).
    \6\ 15 U.S.C. 78s(b)(2)(B).
    \7\ See Securities Exchange Act Release No. 91359 (March 18, 
2021), 86 FR 15734 (March 24, 2021) (``Order Instituting 
Proceedings'').
    \8\ See Securities Exchange Act Release No. 92154 (June 11, 
2021), 86 FR 32301 (June 17, 2021).
---------------------------------------------------------------------------

    This order disapproves the proposed rule change because, as 
discussed below, the Exchange has not met its burden under the Act and 
the Commission's Rules of Practice to demonstrate that its proposal is 
consistent with the requirements of Section 6(b)(5) of the Act and, in 
particular, the requirements that the rules of a national securities 
exchange be designed to promote just and equitable principles of trade 
and to protect investors and the public interest, and not be designed 
to permit unfair discrimination between customers, issuers, brokers, or 
dealers.\9\
---------------------------------------------------------------------------

    \9\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

II. Description of the Proposal

    NYSE Rules 451 and 465, and the related provisions in Section 
402.10 of the Manual, require NYSE member organizations that hold 
securities for beneficial owners in street name to solicit proxies 
from, and deliver proxy and other materials to, beneficial owners on 
behalf of issuers.\10\ For this service, issuers reimburse NYSE member 
organizations for out-of-pocket, reasonable clerical, postage, and 
other expenses incurred for a particular distribution.\11\ This 
reimbursement structure stems from Rules 14b-1 and 14b-2 under the 
Act,\12\ which impose obligations on issuers and nominees to ensure 
that beneficial owners receive proxy materials. These rules require 
issuers to send their proxy materials to broker-dealers or banks that 
hold securities in street name, for forwarding to beneficial owners, 
and to pay nominees for reasonable expenses, both direct and indirect, 
incurred in providing proxy information to beneficial owners.\13\ The 
Commission's rules do not specify the fees that nominees can charge 
issuers for proxy distribution; rather, they state that issuers must 
reimburse the nominees for ``reasonable expenses'' incurred.\14\
---------------------------------------------------------------------------

    \10\ See NYSE Rules 451 and 465, and Section 402.10 of the 
Manual; Notice, supra note 3, 85 FR at 83119. The ownership of 
shares in street name means that a shareholder, or ``beneficial 
owner,'' has purchased shares through a broker-dealer or bank, also 
known as a ``nominee.'' In contrast to direct ownership, where 
shares are directly registered in the name of the shareholder, 
shares held in street name are registered in the name of the 
nominee, or in the nominee name of a depository, such as the 
Depository Trust Company. See Securities Exchange Act Release No. 
70720 (October 18, 2013), 78 FR 63530, 63531 n.14 (October 24, 2013) 
(order approving SR-NYSE-2013-07) (``2013 Approval Order'').
    \11\ See NYSE Rules 451 and 465, and Section 402.10 of the 
Manual; 2013 Approval Order, supra note 10, 78 FR at 63531.
    \12\ 17 CFR 240.14b-1; 17 CFR 240.14b-2.
    \13\ See 17 CFR 240.14b-1 and 14b-2; see also 2013 Approval 
Order, supra note 10, 78 FR at 63531.
    \14\ See 17 CFR 240.14b-1 and 14b-2; see also 2013 Approval 
Order, supra note 10, 78 FR at 63531.
---------------------------------------------------------------------------

    Currently, the Supplementary Material to NYSE Rule 451, which is 
cross-referenced by the Supplementary Material to NYSE Rule 465 and 
Section 402.10 of the Manual, establishes the maximum rates at which a 
NYSE member organization may be reimbursed for certain expenses 
incurred in connection with distributing proxy and other materials to 
beneficial owners. FINRA Rule 2251 also sets forth a schedule of 
maximum rates that is substantively identical to the rate schedule 
specified in NYSE Rule 451.\15\ As a result, any broker that is a FINRA 
member but not also a NYSE member is subject to the same maximum 
reimbursement rates as NYSE members. The rules of other self-regulatory 
organizations (``SROs'') generally provide that member organizations 
must forward proxy and other materials if they receive ``reasonable'' 
reimbursement, but they do not specify any schedule of maximum 
permitted charges.\16\
---------------------------------------------------------------------------

    \15\ See Notice, supra note 3, 85 FR at 83119. The Exchange 
stated that FINRA Rule 2251 differs from NYSE Rule 451 in one 
respect. Specifically, FINRA has not adopted the Notice and Access 
fees for investment company shareholder report distributions set 
forth in Section 5 (Notice and Access Fees) of Supplementary 
Material .90 to NYSE Rule 451 as part of FINRA Rule 2251. See id., 
85 FR at 83119 n.8.
    \16\ See id., 85 FR at 83119. But see NYSE American LLC Rule 
576.80 (setting forth a schedule of approved charges by member 
organizations in connection with proxy solicitations).
---------------------------------------------------------------------------

    The Exchange has proposed to amend Supplementary Materials .90-.96 
to NYSE Rule 451 by deleting the provisions setting maximum 
reimbursement rates and replacing them with rule text stating that 
member organizations must comply with any schedule of approved charges 
set forth in the rules of any other national securities exchange or 
association of which such member organization is a member.\17\ The 
Exchange also has proposed to delete the cross-reference to NYSE Rule 
451.90-.96 in Supplementary Material .20 to NYSE Rule 465 and replace 
it with rule text that is identical to the proposed new language in 
Supplementary Material .90 to NYSE Rule 451.\18\ The Exchange stated 
that the proposed rule change is not intended to take a position on the 
appropriateness of the fee schedules for proxy and other distributions 
currently set forth in NYSE Rules 451 and 465 or in the rules of any 
other SRO.\19\
---------------------------------------------------------------------------

    \17\ See proposed Supplementary Material .90 to NYSE Rule 451. 
The Exchange also proposes to delete Section 402.10 of the Manual, 
which replicates the fee schedule set forth in Supplementary 
Materials .90-.96 to NYSE Rule 451.
    \18\ See proposed Supplementary Material .20 to NYSE Rule 465.
    \19\ See Notice, supra note 3, 85 FR at 83120. As noted above, 
FINRA and NYSE American LLC presently are the only SROs besides NYSE 
with rules that set forth a fee schedule.
---------------------------------------------------------------------------

    According to the Exchange, since all NYSE member organizations that 
are subject to the fee schedule set forth in NYSE Rule 451 (and cross-
referenced by NYSE Rule 465) are also FINRA member firms, the proposal 
would effectively require member organizations to comply with the fee 
schedule set forth in FINRA Rule 2251.\20\ The Exchange acknowledged 
that it has historically taken the lead in establishing the maximum 
proxy distribution reimbursement rates, but stated that it does not 
believe the Exchange is best positioned to retain this responsibility 
going forward.\21\ The Exchange stated that all of the brokers who hold 
shares on behalf of customers in street name are FINRA members, while 
only a subset of them are members of the Exchange.\22\ The Exchange 
also stated that a large and increasing number of the affected issuers 
are listed on Nasdaq, CBOE, or other non-NYSE Group exchanges or are 
traded solely over the counter.\23\ The Exchange further stated that 
the development of the mutual fund industry has led to the existence of 
a large number of issuers that are not listed on any exchange.\24\
---------------------------------------------------------------------------

    \20\ See id.
    \21\ See id., 85 FR at 83119.
    \22\ See id., 85 FR at 83120.
    \23\ See id.
    \24\ See id., 85 FR at 83119-20.
---------------------------------------------------------------------------

III. Discussion and Commission Findings

    Under Section 19(b)(2)(C) of the Act,\25\ the Commission shall 
approve a proposed rule change of an SRO if it finds that such proposed 
rule change is consistent with the requirements of the Act and the 
rules and regulations thereunder that are applicable to such 
organization.\26\ The Commission shall disapprove a proposed rule 
change if it

[[Page 47353]]

does not make such a finding.\27\ The Commission's Rules of Practice, 
under Rule 700(b)(3), state that the ``burden to demonstrate that a 
proposed rule change is consistent with the [Exchange] Act and the 
rules and regulations issued thereunder . . . is on the self-regulatory 
organization that proposed the rule change'' and that a ``mere 
assertion that the proposed rule change is consistent with those 
requirements . . . is not sufficient.'' \28\
---------------------------------------------------------------------------

    \25\ See 15 U.S.C. 78s(b)(2)(C).
    \26\ See 15 U.S.C. 78s(b)(2)(C)(i).
    \27\ See 15 U.S.C. 78s(b)(2)(C)(ii); see also 17 CFR 
201.700(b)(3).
    \28\ See 17 CFR 201.700(b)(3).
---------------------------------------------------------------------------

    The description of a proposed rule change, its purpose and 
operation, its effect, and a legal analysis of its consistency with 
applicable requirements must all be sufficiently detailed and specific 
to support an affirmative Commission finding,\29\ and any failure of an 
SRO to provide this information may result in the Commission not having 
a sufficient basis to make an affirmative finding that a proposed rule 
change is consistent with the Act and the applicable rules and 
regulations.\30\ Moreover, ``unquestioning reliance'' on an SRO's 
representations in a proposed rule change is not sufficient to justify 
Commission approval of a proposed rule change.\31\
---------------------------------------------------------------------------

    \29\ See id.
    \30\ See id.
    \31\ Susquehanna Int'l Group, LLP v. Securities and Exchange 
Commission, 866 F.3d 442, 447 (D.C. Cir. 2017).
---------------------------------------------------------------------------

    For the reasons discussed below, the Commission is disapproving the 
proposed rule change because the information before the Commission is 
insufficient to support a finding that the proposed rule change is 
consistent with the requirements of the Act and the rules and 
regulations thereunder applicable to a national securities exchange. 
Specifically, the Commission concludes that it does not have sufficient 
information to determine that the proposed rule change is consistent 
with Section 6(b)(5) of the Act and, in particular, the requirements 
that a national securities exchange's rules be designed to promote just 
and equitable principles of trade and to protect investors and the 
public interest, and not be designed to permit unfair discrimination 
between customers, issuers, brokers, or dealers.
    As an SRO, the Exchange bears the burden to demonstrate that any 
proposed rule change--whether a proposed new rule, or a proposed 
elimination of an existing rule--is consistent with the Act.\32\ As 
discussed above, the Exchange has proposed to delete its long-standing 
and currently (and widely) relied-upon provisions setting maximum 
reimbursement rates, and instead provide that a NYSE member 
organization must comply with any schedule of approved charges set 
forth in the rules of any other national securities exchange or 
association of which such organization is a member. This effectively 
would make the maximum reimbursement rates set forth in FINRA rules the 
industry standard, and establish FINRA as the lead SRO in this 
area.\33\ Accordingly, the Exchange bears the burden to demonstrate 
that approval of its proposal--which would result in a FINRA-led 
regime--would be consistent with the Act.
---------------------------------------------------------------------------

    \32\ See Rule 700(b)(3), Commission Rules of Practice, 17 CFR 
201.700(b)(3).
    \33\ See supra note 20 and accompanying text.
---------------------------------------------------------------------------

    In the Notice, the Exchange expressed the view that FINRA is in a 
better position to take the lead in setting maximum reimbursement rates 
for the distribution of proxy and other issuer materials to beneficial 
owners because (1) all broker-dealers that hold shares in street name 
for customers are FINRA members, while only a subset of them are NYSE 
members, and (2) a large number of affected issuers are not listed on 
the Exchange.\34\ In the Order Instituting Proceedings, the Commission 
stated that, because NYSE is a primary listing market, it has 
relationships with issuers as well as broker-dealers, and thus is well-
positioned to take into account the views of both major stakeholder 
groups when reviewing and updating the maximum reimbursement rates.\35\ 
The Commission stated that, unlike NYSE, FINRA does not have a 
relationship with issuers, who ultimately pay the reimbursement 
rates.\36\ Further, the Commission stated that the Exchange had not 
explained why, in the absence of a relationship with this important 
constituency, FINRA is in a better position than NYSE to assume the 
leadership role in this area.\37\ The Commission also stated that the 
Exchange had not explained why the fact that all broker-dealers are 
FINRA members puts FINRA in a materially better position to assume the 
leadership role in this area, or the significance of the fact that only 
a subset of impacted issuers are listed on NYSE, and only a subset of 
impacted broker-dealers are NYSE members, given that NYSE would appear 
well-positioned to consider the views of both of these constituencies, 
whereas FINRA would not appear well-positioned to consider issuers' 
views.\38\
---------------------------------------------------------------------------

    \34\ See Notice, supra note 3, 85 FR at 83119-20.
    \35\ See Order Instituting Proceedings, supra note 7, 86 FR at 
15737.
    \36\ See id.
    \37\ See id.
    \38\ See id.
---------------------------------------------------------------------------

    In response to the Order Instituting Proceedings, the Exchange 
argued that being a listing exchange does not give it a meaningful 
advantage in the reimbursement rate-setting process because whether 
such rates are ``reasonable'' is necessarily based on the actual costs 
incurred by brokers, of which issuers have no first-hand knowledge.\39\ 
In addition, the Exchange argued that FINRA is uniquely well-positioned 
to set reimbursement rates because, as the common regulator for all 
brokers whose business includes servicing street-name account holders, 
FINRA can review the actual costs incurred by brokers across the entire 
industry and their intermediaries.\40\ The Exchange stated, in this 
regard, that only a subset of brokers that hold shares on behalf of 
customers in street name are NYSE members, and the NYSE members who 
engage in retail brokerage services primarily consist of larger, more 
established brokers, whereas FINRA's membership is more diverse, 
including smaller regional brokers and digital-only brokers that 
concentrate on serving retail customers.\41\
---------------------------------------------------------------------------

    \39\ See letter from John Carey, Senior Director, NYSE, dated 
April 28, 2021 (``NYSE Response Letter''), at 2.
    \40\ See id. In this context, the Commission understands the 
Exchange's reference to ``intermediaries'' to be a reference to 
proxy service providers that coordinate the distribution of proxy or 
other materials for multiple nominees. See Section 1(a)(ii) of 
Supplementary Material .90 to Rule 451 (defining the term 
``intermediary'').
    \41\ See NYSE Response Letter at 2.
---------------------------------------------------------------------------

    A broker bears an obligation to forward proxies and other issuer 
materials to beneficial owners with street name holdings, but that 
obligation is conditioned upon the broker receiving assurance from the 
issuer of reimbursement of the broker's reasonable expenses incurred in 
connection with performing that obligation.\42\ Under this framework, 
brokers and issuers are both inextricably involved in ensuring that 
beneficial owners with street name holdings receive proxies and other 
issuer materials.
---------------------------------------------------------------------------

    \42\ See 17 CFR 240.14b-1.
---------------------------------------------------------------------------

    The Exchange's arguments do not provide a sufficient basis for the 
Commission to find that the proposed rule change would be consistent 
with Section 6(b)(5) of the Act because the Exchange has not 
demonstrated how issuers' interests would continue to be adequately 
considered, and not unfairly discriminated against, in the 
reimbursement rate-setting process if the Exchange were to relinquish 
its lead

[[Page 47354]]

role in this area. The Commission is not foreclosing the possibility 
that issuers' interests could be adequately considered in a 
reimbursement rate-setting process that the Exchange does not lead; 
however, in the Notice and in its response to the Order Instituting 
Proceedings, the Exchange did not provide sufficient information in the 
record on this point. In particular, while the Exchange acknowledges 
that the impact of eliminating the reimbursement rate schedule from its 
rules would be that FINRA becomes the de facto lead SRO for rate 
setting,\43\ the Exchange does not articulate or provide any 
information to suggest how FINRA, notwithstanding its lack of 
regulatory relationships with issuers, could potentially consider 
issuers' interests if FINRA were to become the industry standard-
bearer.\44\ Nor does the Exchange identify any other existing mechanism 
through which the interests of issuers could be adequately considered 
if proposed updates to the rates were to be developed under a FINRA-led 
regime.
---------------------------------------------------------------------------

    \43\ See Notice, supra note 3, 85 FR at 83120.
    \44\ FINRA, along with several other commenters, opposed the 
proposal because FINRA, unlike the Exchange, has no regulatory 
relationship with issuers. See letters from: Marcia E. Asquith, 
Executive Vice President, FINRA, dated January 11, 2021 (``First 
FINRA Letter''), at 5, and dated April 14, 2021 (``Second FINRA 
Letter''), at 3; Niels Holch, Executive Director, Shareholder 
Communications Coalition, dated January 20, 2021 (``SCC Letter''), 
at 5; Todd J. May, President, Securities Transfer Association, Inc., 
dated March 1, 2021 (``First STA Letter''), at 2, and dated April 
14, 2021 (``Second STA Letter''), at 5; Paul Conn, President, Global 
Capital Markets, Computershare, dated January 11, 2021 (``First 
Computershare Letter''), at 3-4, and dated April 14, 2021 (``Second 
Computershare Letter''), at 1. FINRA also stated that it is not in a 
better position than NYSE to become the lead SRO in this area, and 
that, should the Commission determine to approve the Exchange's 
proposal, FINRA would be strongly inclined to rescind its fee 
schedule as well. See First FINRA Letter at 5-6; Second FINRA Letter 
at 3. The Commission notes that any FINRA proposal to rescind its 
fee schedule would be subject to the rule filing process and 
Commission approval.
     Commenters were divided on the desirability of retaining a 
fixed maximum rate schedule. See letters from: Thomas F. Price, 
Managing Director, Operations, Technology, Cyber & BCP, Securities 
Industry and Financial Markets Association, dated April 14, 2021, at 
5 (recommending that the Commission ensure that at least one 
significant SRO retains a fixed maximum fee schedule); Sarah A. 
Bessin, Associate General Counsel, Securities Regulation, and Joanne 
Kane, Senior Director, Operations and Transfer Agency, Investment 
Company Institute, dated May 13, 2021 (``Second ICI Letter''), at 4 
(stating that retaining a fixed SRO rate schedule would be an 
inappropriate means of broader reform). See also infra note 52.
---------------------------------------------------------------------------

    In contrast, for the many years that the Exchange has been the lead 
SRO in this area, it has demonstrated the ability, as a primary listing 
market that has relationships with both brokers and issuers, to 
consider the interests of both of these important constituencies when 
it periodically develops proposals to update the reimbursement rate 
schedule pursuant to Section 19(b)(2) of the Act. In so doing, the 
Exchange performs an important SRO function of generating proposals 
that provide a basis for the Commission to find that the proposed 
updated rates constitute an equitable allocation of reasonable 
fees.\45\ As an outgrowth of this process and as approved by the 
Commission, the NYSE rate schedule sets the maximum level of 
``reasonable'' reimbursement that is accepted as the industry standard 
for what may be sought by any broker and must be paid by any issuer. In 
turn, as a consensus product representing broker and issuer interests, 
the NYSE rate schedule helps ensure that beneficial owners receive 
proxy and other issuer materials in a timely manner and as required by 
the Commission's rules.
---------------------------------------------------------------------------

    \45\ See 15 U.S.C. 78f(b)(4).
---------------------------------------------------------------------------

    The Exchange's statements regarding FINRA's ability to consider 
brokers' costs do not evince a similar ability on FINRA's part to 
consider both broker and issuer interests in performing this SRO 
function. Moreover, while the Exchange asserts that its listing 
relationships with issuers do not provide it with a meaningful 
advantage in the reimbursement rate-setting process, the consideration 
of issuers' interests has been a fundamental part of the Exchange's 
process for determining what reimbursement rates would be 
``reasonable.'' Throughout the history of the NYSE reimbursement rates, 
which were formally established by rule in 1952 and have been updated 
periodically since then,\46\ both issuers and brokers have been 
involved in the process of reaching a workable consensus as to what 
constitutes ``reasonable'' reimbursement.\47\ The Exchange's own, most 
recent history on this point is illustrative. In 2010, the Exchange 
formed a Proxy Fee Advisory Committee, comprised of representatives of 
issuers, broker-dealers, and shareholders, to make recommendations for 
changes to the Exchange's then-existing reimbursement schedule; \48\ 
and in 2013, when the last major revisions to the reimbursement 
schedule were proposed, the Exchange acknowledged that it has ``long 
operated under the assumption that these fees should represent a 
consensus view of the issuers and the broker-dealers involved.'' \49\ 
The Exchange's historical approach underscores that the ability to duly 
consider both brokers' and issuers' interests--an ability that, based 
on the record here, FINRA does not possess--is critical to an equitable 
and fair process for determining what rates would constitute reasonable 
reimbursement, and helps assure that the rates are set in a manner 
that, consistent with Section 6(b)(5), promotes just and equitable 
principles of trade, protects investors and the public interest, and 
does not permit unfair discrimination between customers, issuers, 
brokers, or dealers.
---------------------------------------------------------------------------

    \46\ See Concept Release on the U.S. Proxy Systems, Securities 
Exchange Act Release No. 62495 (July 14, 2010), 75 FR 42981, 42995 
(July 22, 2010) (``Proxy Plumbing Release'').
    \47\ See 2013 Approval Order, supra note 10, 78 FR at 63538 
n.164.
    \48\ See Securities Exchange Release No. 68936 (February 15, 
2013), 78 FR 12381, 12382 (February 22, 2013) (SR-NYSE-2013-07).
    \49\ See id. In fact, issuers may provide perspective not just 
based on their experience paying the NYSE reimbursement rates, but 
also based on their experience paying to distribute materials to 
registered owners who do not hold their shares in street name, which 
distributions do not involve brokers and are not subject to the NYSE 
rates. See Proxy Plumbing Release, supra note 46, 75 FR at 42986. 
Issuers typically contract directly with third-party service 
providers for distributions to registered owner accounts, just as 
brokers typically contract with third-party service providers for 
distributions to street name accounts. See id. While these different 
types of distributions might involve different costs and processes, 
issuers have insight into what it costs to pay a service provider to 
distribute proxies or other issuer materials that is relevant to the 
reimbursement rate-setting process. See, e.g., letter from Dorothy 
M. Donohue, Deputy General Counsel, Securities Regulation, and 
Joanne Kane, Senior Director, Operations and Transfer Agency, 
Investment Company Institute, dated January 8, 2021 (``First ICI 
Letter''), at 2 and Second ICI Letter at 2-3 (comparing the costs 
that funds pay when they distribute materials through intermediaries 
to what they pay when they distribute materials directly to 
shareholders).
---------------------------------------------------------------------------

    In addition, the Exchange argued that its proposal would simply 
conform its rules to substantively identical rules of other exchanges, 
such as Cboe BZX Exchange and the Investors Exchange, that do not 
specify a schedule of maximum permitted reimbursement rates.\50\ The 
mere fact that other exchanges' rules do not specify a reimbursement 
rate schedule does not demonstrate that the Exchange's proposal is 
consistent with the Act and must be approved, or that the circumstances 
that make those other exchanges' rules consistent with the Act apply 
equally to the Exchange.\51\ Indeed, the circumstances underpinning 
this proposal are unique because, as noted above, the NYSE rate 
schedule is the product of a NYSE-led process that considers broker and 
issuer interests

[[Page 47355]]

and is the industry standard that all brokers with street name accounts 
and issuers rely upon. Approval of NYSE's proposed elimination of its 
rate schedule therefore would do more than simply conform NYSE's rules 
to those of other exchanges; it would result in NYSE's relinquishment 
of an important market-wide regulatory function that it currently 
performs, and without there being evidence in the record of this filing 
of an available and equally viable alternative for that function.
---------------------------------------------------------------------------

    \50\ See NYSE Response Letter at 2.
    \51\ We note that, as set forth in Commission Rule of Practice 
700(b)(3) (17 CFR 201.700(b)(3)), a ``mere assertion . . . that 
another self-regulatory organization has a similar rule in place'' 
is ``not sufficient'' to ``explain why the proposed rule change is 
consistent with the requirements of the Act and the rules and 
regulations thereunder applicable to a self-regulatory 
organization.''
---------------------------------------------------------------------------

    When assessing this proposed rule change, the Commission must 
consider its consistency with the Act and the applicable rules and 
regulations issued thereunder.\52\ As stated above, under the 
Commission's Rules of Practice, the ``burden to demonstrate that a 
proposed rule change is consistent with the [Exchange] Act and the 
rules and regulations issued thereunder . . . is on the self-regulatory 
organization that proposed the rule change.'' \53\ For the foregoing 
reasons, the Exchange has not met its burden to demonstrate that it 
would be consistent with the Act for the Exchange to relinquish its 
current role in setting the maximum reimbursement rates that establish 
the industry standard. In particular, the Exchange has not adequately 
demonstrated that, in its absence from that role, issuer interests 
would continue to be considered and not unfairly discriminated against. 
As a result, the Commission does not have sufficient information to 
find that the Exchange's proposal would promote just and equitable 
principles of trade and protect investors and the public interest, and 
not permit unfair discrimination between customers, issuers, brokers, 
or dealers. Accordingly, the Commission must disapprove the proposal 
because the Exchange has not met its burden to demonstrate that the 
proposal is consistent with Section 6(b)(5) of the Act.\54\
---------------------------------------------------------------------------

    \52\ The Commission notes that almost all commenters urged 
comprehensive, Commission-led reform to the current reimbursement 
structure. See First FINRA Letter, Second FINRA Letter, First STA 
Letter, Second STA Letter, First Computershare Letter, Second 
Computershare Letter, SCC Letter, First ICI Letter, Second ICI 
Letter. See also letters from: Timothy W. McHale, Senior Vice 
President & Senior Counsel, Capital Research and Management Company, 
and Anthony M. Seiffert, Chief Compliance Officer, American Funds 
Service Company, dated January 11, 2021; Catherine L. Newell, 
General Counsel and Executive Vice President, Dimensional Fund 
Advisors LP, dated January 11, 2021; Peter J. Germain, Chief Legal 
Officer, Federated Hermes, Inc., dated January 11, 2021; Basil K. 
Fox, Jr., President, Franklin Templeton Investor Services, LLC, 
dated January 11, 2021; Heidi Hardin, Executive Vice President and 
General Counsel, MFS Investment Management, dated January 11, 2021; 
Thomas E. Faust Jr., Chairman and Chief Executive Officer, Eaton 
Vance Corp., dated January 14, 2021; Noah Hamman, Chief Executive 
Officer, AdvisorShares Investments, LLC, dated January 14, 2021; 
Timothy W. McHale, Senior Vice President & Senior Counsel, Capital 
Research and Management Company, and Anthony M. Seiffert, Chief 
Compliance Officer, American Funds Service Company, dated May 18, 
2021; and Heidi Hardin, Executive Vice President and General 
Counsel, MFS Investment Management, dated May 19, 2021. The 
Commission must consider the proposed rule change that was filed, 
and thus such reform is beyond the scope of this proposed rule 
change. As noted above, the Exchange stated that the proposed rule 
change is not intended to take a position on the appropriateness of 
the fee schedules for proxy and other distributions currently set 
forth in NYSE Rules 451 and 465 or in the rules of any other SRO. 
See supra note 19 and accompanying text.
    \53\ Rule 700(b)(3), Commission Rules of Practice, 17 CFR 
201.700(b)(3).
    \54\ In disapproving this proposed rule change, the Commission 
has considered the proposed rule's impact on efficiency, 
competition, and capital formation. See 15 U.S.C. 78c(f).
---------------------------------------------------------------------------

IV. Conclusion

    For the reasons set forth above, the Commission does not find, 
pursuant to Section 19(b)(2) of the Act, that the proposed rule change 
is consistent with the requirements of the Act and the rules and 
regulations thereunder applicable to a national securities exchange, 
and in particular, with Section 6(b)(5) of the Act.\55\
---------------------------------------------------------------------------

    \55\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

    It is therefore ordered, pursuant to Section 19(b)(2) of the 
Act,\56\ that the proposed rule change (SR-NYSE-2020-96) is 
disapproved.
---------------------------------------------------------------------------

    \56\ 15 U.S.C. 78s(b)(2).
    \57\ 17 CFR 200.30-3(a)(12).

    For the Commission, by the Division of Trading and Markets, 
pursuant to delegated authority.\57\
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2021-18119 Filed 8-23-21; 8:45 am]
BILLING CODE 8011-01-P